Roche signs deal to acquire Schroders’s Carmot Therapeutics for upto $3.1 billion
LONDON, UK: Schroders Capital’s portfolio company Carmot Therapeutics Inc. has entered into a definitive agreement to be acquired by Roche, a global pharmaceutical company, at...
Roche buys Telavant for $7.1 billion, gains access to novel IBD drug
Roche, a Swiss pharmaceutical giant, has agreed to a US$7.1 billion deal to acquire Telavant, a biotech company that is developing a promising drug for...
Oncimmune Holdings signs agreements with Roche and Cedars-Sinai
LONDON: Oncimmune Holdings plc has signed two separate agreements with Roche Pharmaceuticals and Cedars-Sinai Medical Center, in each case to use the company’s newly developed...